Infection-blocking dental implant

Information

  • Patent Grant
  • 8221499
  • Patent Number
    8,221,499
  • Date Filed
    Monday, January 25, 1999
    26 years ago
  • Date Issued
    Tuesday, July 17, 2012
    12 years ago
Abstract
An infection-blocking dental implant in which a threaded portion which contacts bone is roughened except for up to three threads which may be exposed by bone recession after implantation, which have a smooth surface. Preferably, the implant is of titanium or titanium alloy and the threaded portion is roughened by a two-step acid treatment.
Description
FIELD OF THE INVENTION

This invention relates to dental implants intended for insertion in a hole provided in living jawbone for eventual support of artificial teeth. It is illustrated as realized in a cylindrical dental implant having a screw thread or screw threads on its outer surface, but it is not limited to that type of implant, and is applicable to all types of implants which share the general characteristic that while they are fitted into the living jawbone they extend out of it through the overlying gingival into the mouth wherein they support artificial teeth.


BACKGROUND OF THE INVENTION

The part of a dental implant that is in the living jawbone should have a roughened surface confronting the host bone for bonding with the bone, and the part of the same implant that is exposed in the mouth should have a smooth surface because a rough surface in that location might provide a site where bacteria can attach and proliferate. For hygienic reasons the exposed surfaces of the implant should be smooth, while for osseointegration purposes the surfaces of the implant confronting the host bone should be rough. Experience over many years has taught dentists practicing implantology that approximately eighteen months after an implant has been successfully placed in the jawbone of a patient and is performing its task of supporting artificial dentition, the bone surrounding the implant immediately beneath the overlying gingival tissue will in most cases be found to have receded a small distance, exposing to the soft tissue a portion of the roughened surface of the implant which had been in bone. This phenomenon is illustrated in a book by Branemark, Zarb & Albrektsson entitled “Tissue-Integrated Prostheses” 1985, p56, FIG. 1-46. This event, occurring as it does beneath the gum tissue surrounding an artificial tooth, is not immediately visible. In spite of the most diligent hygienic practice, it presents the danger that bacteria which succeed in penetrating between the tooth and its surrounding tissue may attach themselves to the roughened surface, and there proliferate, and bring about an infection putting the implant and the tooth it supports in danger of failure.


In U.S. Pat. No. 4,988,299 an implant is disclosed which has a threaded portion and a smooth neck portion. No reference is made to roughening of the threaded portion or how smooth the neck portion should be. The neck portion is defined by having a diameter between the “core” diameter of the threaded portion and the outer diameter of the threads and it is disclosed to have a curved surface. The neck portion is said to have an axial length exceeding the settlement in bone level and it is intended to avoid exposure of the threads.


SUMMARY OF THE INVENTION

The present invention relates to an implant which is roughened to improve osseointegration with the bone but which does not provide a surface which can facilitate infection.


Observations based on practical experience of one of the present inventors over the past ten years or more have revealed that the recession described in the above-mentioned book tends to stop at the level where the implant places a load on the host bone. In a screw-type implant this level is approximately the beginning of the first turn of the screw thread near the gingival end of the implant. However, these observations also indicate that the stopping level is not precisely the same in all cases, and that in some cases the first thread may be exposed. At times, more than one thread is exposed, perhaps up to three threads.


According to the invention as illustrated in the accompanying drawings, the portion of the implant which has a roughened surface is limited to that portion which can be expected to remain in contact with the host bone after the expected bone recession has taken place. The head portion of the implant and the immediately-adjacent part of the heretofore roughened portion, including the initial part of the screw threads, are made smooth. Preferably one to three threads will be left smooth, not roughened. Typically, a length of about 3 mm below the top surface of the implant will be left smooth and not roughened with the remainder of the implant. Because the amount of bone that recedes will vary with different patients, one or more smooth threads may remain permanently in the bone along with the roughened threads. Although these smooth threads may not load the bone to the same degree as the roughened threads, nevertheless the smooth threads will still add significantly to the bone loading.


Since the exact amount of bone recession that will occur in a given patient cannot be determined in advance of the event with precision, the invention is useful to minimize the danger of infection from this source, that is, to block the infection. Good hygienic practice will continue to be required of the patient. With the invention, such good practice can be expected to be more fruitful than heretofore.





BRIEF DESCRIPTION OF THE DRAWINGS

The invention is described in greater detail with reference to the accompanying drawings, in which:



FIG. 1 is a side elevation of a dental implant according to the invention;



FIG. 2 is an end view of the dental implant of FIG. 1.



FIGS. 3A and 3B are scanning electron micrographs (“SEMs”) of two titanium dental implants prepared in accordance with the present invention;



FIGS. 4A and 4B are SEMs of the same implants shown in FIGS. 3A and 3B, at a higher magnification level;



FIG. 5 is a graph of the results of an Auger electron spectroscopic analysis of a titanium surface that has been exposed to air;



FIGS. 6A and 6B are SEMs of two titanium dental implants prepared in accordance with the present invention; and



FIGS. 7A and 7B are SEMs of the same implants shown in FIGS. 7A and 7B, at a higher magnification level.





DETAILED DESCRIPTION OF THE INVENTION

The implant 10 has a head portion 12, a neck portion 14 and a main body 16 which is roughened on its outer surface in the region 18. Such implants are normally machined from titanium or a titanium alloy and are smooth, until a portion is roughened to facilitate osseointegration with bone. The head portion 12, the neck portion 14, and a small region 20 of the main body 16 immediately adjacent the neck portion, encompassing the first to third thread turns, are smooth. To achieve this result the portions of the implant intended to remain smooth during and after the roughening procedure may be covered during that procedure. For example, if the roughening procedure includes an acid-etching step or steps, these parts may be covered with a suitable wax prior to immersing the implant in the etching acid. A preferred method of roughening the surface is disclosed in U.S. Pat. No. 5,876,453 mentioned above and incorporated by reference herein. The process has two steps, the first being removal of native oxide from titanium by contact with an aqueous hydrofluoric acid solution, followed by etching with a mixture of sulfuric and hydrochloric acids.


When the implant 10 is first installed in a bore prepared for it in a patient's jawbone, the implant is buried in bone up to and including the head portion 12, to the level indicated by line A-A in FIG. 1. The healing phase then begins, during which new bone is formed close to the immobile, resting implant, and the implant will remain buried in the bone, up to the head portion. All the implant, including the neck portion 12, will confront the host bone in the early part of the healing phase. Thereafter when the implant is loaded and the remodeling phase begins (overlapping the healing phase) during exposure to masticatory forces, the newly formed bone remodels under the applied load until, after about eighteen months, a steady state is achieved. In this state the anchoring bone will be found to have undergone a reduction in height (bone recession) immediately adjacent the implant. The amount of this recession can vary from case to case, between the level indicated by the solid curved lines 30 and the level indicated by the broken curved lines 32, for example, exposing the head portion 12, the neck portion 14 and some or all of the immediately adjacent region 20 of the threaded main body 16. In some cases region 20 may extend further, up to about the third thread. Another way to define regions 14 and 20 is that roughening of the implant begins about 3 mm below the upper flat surface 15 of the implant 10, which receives connecting parts of the dental restoration.


According to the invention, that region 20 immediately adjacent to the neck portion 14 of the implant is maintained smooth so that when the remodeling phase is completed, there will be little or no roughened implant surface exposed to the soft tissue under the dental restoration that is supported on the implant. The exact dimensions of the smooth region 20 cannot be precisely established for all cases. A length corresponding to about one turn of the screw thread is suitable for many cases, but up to three threads may be left smooth.


The manner in which the surface of the implant is roughened and the resulting surface topography will now be described. According to one aspect of the present invention, the native oxide layer is removed from the surface of a titanium implant prior to the final treatment of the surface to achieve the desired topography. After the native oxide layer is removed, a further and different treatment of the surface is carried out in the absence of unreacted oxygen to prevent the oxide layer from reforming until after the desired surface topography has been achieved. It has been found that this process permits the production of unique surface conditions that are substantially uniform over the implant surface that is so treated.


Removal of the native oxide layer can be effected by immersing the titanium implant in an aqueous solution of hydrofluoric (HF) acid at room temperature to etch the native oxide at a rate of at least about 100 Angstroms per minute. A preferred concentration for the hydrofluoric acid used in this oxide removal step is 15% HF/H2O. This concentration produces an etch rate of approximately 200-350 Angstroms per minute at room temperature, without agitation, so that a typical native oxide layer having a thickness in the range from about 70 to about 150 Angstroms can be removed in about one-half minute. Other suitable etching solutions for removing the native oxide layer, and their respective etch rates, are:

  • 50% HF—etch rate about 600 to 750 Angstroms/min.
  • 30% HF—etch rate about 400 to 550 Angstroms/min.
  • 10% HF—etch rate about 100 to 250 Angstroms/min.


A 100% HF was found to be difficult to control, and the etch rate was not determined. The preferred 15% HF solution allows substantially complete removal of the native oxide layer with minimum further consumption of the titanium surface after the implant is removed from the solution.


The native oxide layer may be removed by the use of other acids, or by the use of techniques other than acid etching. For example, the Swart et al. article cited above mentions the use of plasma cleaning to remove thin oxides. Regardless of what technique is used, however, it is important to remove substantially all the native oxide from the implant surface that is intended to interface with the living bone, so that the subsequent treatment of that surface produces a substantially uniform surface texture to promote uniform bonding to the living bone. The native oxide layer is preferably removed from substantially the entire bone-interfacing surface of the implant. In the case of screw-type dental implants, the bone-interfacing surface typically includes the entire implant surface beyond a narrow collar region on the side wall of the implant at the gingival end thereof. This narrow collar region preferably includes the first turn of the threaded portion of the implant. It is preferred not to etch the gingival end itself, as well as the narrow collar region, because these portions of the implant are normally fabricated with precise dimensions to match abutting components which are eventually attached to the gingival end of the implant. Moreover, it is preferred to have a smooth surface on that portion of a dental implant that is not embedded in the bone, to minimize the risk of infection.


The treatment that follows removal of the native oxide layer must be different from the treatment that is used to remove the native oxide layer. A relatively aggressive treatment is normally required to remove the oxide layer, and such an aggressive treatment does not produce the desired uniform surface texture in the resulting oxide-free surface. Thus, after the native oxide layer has been removed, the resulting implant surface is immediately rinsed and neutralized to prevent any further attack on the implant surface. The surface is then subjected to the further, and different, treatment to produce a desired uniform, surface texture. For example, the preferred further treatment described below is a relatively mild acid-etching treatment which forms a multitude of fine cone-like structures having relatively uniform, small dimensions. Because of the prior removal of the native oxide layer, even a mild second treatment of the implant surface can produce a substantially uniform effect over substantially the entire bone-interfacing surface of the implant.


Prior to removing the native oxide layer, the oxide-bearing surface may be grit blasted, preferably with grit made of titanium or a dilute titanium alloy. As is taught in the U.S. Patent No. 5,607,480, the use of a grit made of titanium avoids contaminating the surface of a titanium implant. Thus, for a dental implant made of commercially pure (“CP”) titanium, the blasting material may be CP B299 SL grade titanium grit.


The preferred particle size for this grit is in the range from about 10 to about 60 microns (sifted), and the preferred pressure is in the range from about 50 to about 80 psi.


The surface treatment that follows removal of the native oxide layer from the implant surface may take several forms, singly or in combination. The preferred treatment is a second acid etching step, using an etch solution (“Modified Muriaticetch”) consisting of a mixture of two parts by volume sulfuric acid (96% by weight H2 SO4, 4% by weight water) and one part by volume hydrochloric acid (37% by weight HCl, 63% by weight water) at a temperature substantially above room temperature and substantially below the boiling point of the solution, preferably in the range from about 60° C. to about 80° C. This mixture provides a sulfuric acid/hydrochloric acid ratio of about 6:1. This preferred etch solution is controllable, allowing the use of bulk etch times in the range from about 3 to about 10 minutes. This solution also can be prepared without the risk of violent reactions that may result from mixing more concentrated HCl solutions (e.g., 98%) with sulfuric acid. This second etching treatment is preferably carried out in the absence of unreacted oxygen, and before the implant surface has been allowed to re-oxidize, following removal of the native oxide layer. Of course, the implants may be kept in an inert atmosphere or other inert environment between the two etching steps.


The second etching step produces a surface topography that includes many fine projections having a cone-like aspect in the sub-micron size range. Because of the fine roughness of the surface, and the high degree of uniformity of that roughness over the treated surface, the surface topography produced by this process is well suited for osseointegration with adjacent bone. As illustrated by the working examples described below, the final etched surface consists of a substantially uniform array of irregularities having peak-to-valley heights of less than about 10 microns. Substantial numbers of the irregularities are substantially cone-shaped elements having base-to-peak heights in the range from about 0.3 microns to about 1.5 microns. The bases of these cone-shaped elements are substantially round with diameters in the range from about 0.3 microns to about 1.2 microns, and spaced from each other by about 0.3 microns to about 0.75 microns. The SEMs discussed below, and reproduced in the drawings, illustrate the surface topography in more detail.


The acid-etched surface described above also provides a good site for the application of various materials that can promote bonding of the surface to adjacent bone. Examples of such materials are bone-growth-enhancing materials such as bone minerals, bone morphogenic proteins, hydroxyapatite, whitlockite, and medicaments. These materials are preferably applied to the etched surface in the form of fine particles which become entrapped on and between the small cone-like structures. The bone-growth-enhancing materials are preferably applied in the absence of oxygen, e.g., using an inert atmosphere.


The roughness of the surface to which these materials are applied enhances the adherence of the applied material to the titanium implant. The uniformity of the rough surface enhances the uniformity of the distribution of the applied material, particularly when the material is applied as small discrete particles or as a very thin film.


A preferred natural bone mineral material for application to the etched surface is the mineral that is commercially available under the registered trademark “BIO-OSS”. This material is a natural bone mineral obtained from bovine bone; it is described as chemically comparable to mineralized human bone with a fine, crystalline biological structure, and able to support osseomtegration of titanium fixtures.


The invention will be further understood by reference to the following examples, which are intended to be illustrative and not limiting:


EXAMPLE NO. 1

A batch of 30 screw-type cylindrical implants made of CP titanium were grit blasted using particles of CP B299 SL grade titanium grit having particle sizes ranging from 10 to 45 microns, at a pressure of 60 to 80 psi. After grit-blasting, native oxide layer was removed from the implant surfaces by placing 4 implants in 100 ml. of a 15% solution of HF in water at room temperature for 30 seconds. The implants were then removed from the acid, neutralized in a solution of baking soda, and placed in 150 ml. of “Modified Muriaticetch” (described above) at room temperature for 3 minutes. The implants were then removed from the acid, neutralized, rinsed and cleaned. All samples displayed very similar surface topographies and a high level of etch uniformity over the surface, when compared with each other in SEM evaluations. Consistency in the surface features (peaks and valleys) was also observed. The SEMs in FIGS. 3A, 3B, 4A and 4B show the surfaces of two of the implants, Sample A-1 and Sample A-4, at magnifications of 2,000 and 20,000. It will be observed that the surface features over the areas shown are consistent and uniform. The scale shown on the ×20,000 photographs is 1 micron=0.564 inch. At this magnification the surfaces appear to be characterized by a two-dimensional array of cones ranging in height (as seen in the SEMs) from about 0.17 inch to about 0.27 inch; the base diameters of these cones varied from about 0.17 inch to about 0.33 inch. Converting these numbers to metric units on the above-mentioned scale (1 micron=0.564 inch) yields:

  • cone height range (approx.)=0.30 to 0.50 micron
  • cone base diameter range (approx.)=0.30 to 0.60 micron.


The same degree of uniformity was found in all the samples, and from sample to sample, at magnifications of 2,000 and 20,000, as compared with similar samples subjected to bulk etching without prior removal of the native oxide, as described in EXAMPLE NO. 2 below.


EXAMPLE NO. 2

Four of the implants that had been grit blasted as described in EXAMPLE NO. 1 above were placed in 150 ml. of “Modified Muriaticetch” for 10 minutes. The implants were then removed, neutralized, rinsed and cleaned. SEM photographs taken at magnifications of 2,000 and 20,000 showed that the bulk etch solution failed to remove the native oxide layer after 10 minutes in the etch solution. The failure to remove the native oxide layer (100-150 Angstrom units thick) resulted in a non-uniformly etched surface, as depicted for example in FIG. 3 of U.S. Pat. No. 5,876,453. In areas of the implant surfaces where the native oxide was removed, the topography was similar to that observed on the implants in EXAMPLE NO. 1.


EXAMPLE NO. 3

The procedure of this example is currently preferred for producing commercial implants. A batch of screw-type implants made of CP titanium were immersed in a 15% solution of HF in water at room temperature for 60 seconds to remove the native oxide layer from the implant surfaces. A plastic cap was placed over the top of each implant to protect it from the acid. The implants were then removed from the acid and rinsed in a baking soda solution for 30 seconds with gentle agitation. The implants were then placed in a second solution of baking soda for 30 seconds, again with agitation of the solution; and then the implants were rinsed in deionized water. Next the implants were immersed in another solution of two parts by volume sulfuric acid (96% by weight H2 SO4, 4% by weight water),and one part by volume hydrochloric acid (37% by weight HCl, 63% by weight water) at 70° C. for 5 minutes. The implants were then removed from the acid and rinsed and neutralized by repeating the same steps carried out upon removal of the implants from the HF. All samples displayed very similar surface topographies and a high level of etch uniformity over the surface, when compared with each other in SEM evaluations. Consistency in the surface features (peaks and valleys) was also observed. The SEMs in FIGS. 6A, 6B, 7A and 7B show the surfaces of two of the implants, Sample 705MB and Sample 705MC, at magnifications of 2,000 and 20,000. It will be observed that the surface features over the areas shown are consistent and uniform. The scale shown on the ×20,000 photographs is 1 micron=0.564 inch. At this magnification the surfaces appear to be characterized by a two-dimensional array of cones ranging in height (as seen in the SEMs) from about 0.17 inch to about 1.128 inch; the base diameters of these cones varied from about 0.17 inch to about 1.128 inch. Converting these numbers to metric units on the above-mentioned scale (1 micron=0.564 inch) yields:

  • cone height range (approx.)=0.30 to 2.0 microns
  • cone base diameter range (approx.)=0.30 to 2.0 microns.


The same degree of uniformity was found in all the samples, and from sample to sample, at magnifications of 2,000 and 20,000, as compared with similar samples subjected to bulk etching without prior removal of the native oxide, as described in EXAMPLE NO. 2 above.

Claims
  • 1. A dental implant made of titanium metal, comprising: a smooth head portion for receiving a dental restoration component;a lowermost end opposing said head portion;a threaded portion for engaging bone between said head portion and said lowermost end; anda roughened region for facilitating osseointegration with said bone located on said threaded portion and extending to said lowermost end of said implant, said roughened region being uniformly acid etched with a second acid solution after a native oxide layer had been removed by contact with a first acid solution with minimum consumption of said titanium metal, said roughened region including an array of irregularities having peak-to-valley heights not greater than about 10 microns wherein said second acid solution is a mixture of sulfuric and hydrochloric acids.
  • 2. A titanium metal dental implant of claim 1, wherein said first acid solution is aqueous hydrofluoric acid.
  • 3. A titanium metal dental implant of claim 1, wherein said irregularities include cone-shaped elements.
  • 4. A titanium dental implant, comprising: a head portion for receiving a dental restoration component, said head portion including a non-rotational feature for engaging said dental restoration component, said head portion having a smooth machined surface;a lowermost end opposing said head portion; anda threaded portion having continuous thread turns and being located between said head portion and said lowermost end, said threaded portion including a self-tapping region adjacent to said lowermost end, said threaded portion having an acid-etched surface for facilitating osseointegration with said bone, said acid-etched surface extending to said lowermost end of said implant and within said self-tapping region, said acid-etched surface being produced on said threaded portion after a native oxide layer has been removed from said threaded surface, said acid-etched surface having an array of irregularities having peak-to-valley heights not greater than about 10 microns, said irregularities including cone-shaped elements.
  • 5. The implant of claim 4, said acid-etched surface is located on said threaded portion below the first uppermost turn of said threaded portion.
  • 6. The implant of claim 4, wherein said native oxide is removed by a first acid solution after which the resulting surface is etched with a second acid solution to create said acid-etched surface.
  • 7. The implant of claim 6, said first acid solution is aqueous hydrofluoric acid.
  • 8. The implant of claim 7, wherein said second acid solution is a mixture of sulfuric and hydrochloric acids.
  • 9. A titanium dental implant, comprising: a head portion for receiving a dental restoration component, said head portion including a non-rotational feature for engaging said dental restoration component;a lowermost end opposing said head portion; anda threaded portion having continuous thread turns and being located between said head portion and said lowermost end, said threaded portion including a cylindrical section and a tapered section immediately adjacent to said lowermost end, said cylindrical section being longer than said tapered section, said tapered section including a self-tapping region that extends to said lowermost end, said threaded portion having an acid-etched surface for facilitating osseointegration with said bone, said acid-etched surface extending from said lowermost end and into said cylindrical section of said threaded portion, said acid-etched surface being produced on said threaded portion after a native oxide layer has been removed from said threaded portion, said acid-etched surface having an array of irregularities having peak-to-valley heights not greater than about 10 microns, said irregularities including cone-shaped elements.
  • 10. The implant of claim 9, said acid-etched surface extends from said lowermost end to at least an uppermost turn of said threaded portion.
  • 11. The implant of claim 9, wherein said native oxide is removed by a first acid solution after which the resulting surface is etched with a second acid solution.
  • 12. The implant of claim 11, said first acid solution is aqueous hydrofluoric acid.
  • 13. The implant of claim 11, wherein said second acid solution is a mixture of sulfuric and hydrochloric acids.
  • 14. The implant of claim 9, further including a neck portion between said head portion and said threaded portion.
  • 15. The implant of claim 14, wherein said neck portion is a smooth machined surface, said head portion having a smooth machined surface.
  • 16. The implant of claim 9, wherein said head portion has a smooth machined surface.
CROSS REFERENCES TO RELATED APPLICATIONS

This application is a continuation of U.S. application Ser. No. 08/778,503, filed Jan. 3, 1997, now issued as U.S. Pat. No. 5,863,201, which is a complete application claiming the benefit of U.S. Provisional Application No. 60/009,592, filed Jan. 4, 1996, and which is also a continuation-in-part of U.S. application Ser. No. 08/607,903, filed Feb. 27, 1996, now issued as U.S. Pat. No. 5,876,453, which, in turn, claims priority to PCT/US95/15576 and is a continuation-in-part of U.S. application Ser. No. 08/351,214, filed Nov. 30, 1994, now abandoned the parent of U.S. application Ser. No. 08/650,594, now issued as U.S. Pat. No. 5,603,338.

US Referenced Citations (116)
Number Name Date Kind
3022783 Tucker, Jr. Feb 1962 A
3605123 Hahn Sep 1971 A
3767437 Cruz, Jr. Oct 1973 A
3790507 Hodosh Feb 1974 A
3855638 Pilliar Dec 1974 A
3919723 Heimke et al. Nov 1975 A
3986212 Sauer Oct 1976 A
3987499 Scharbach et al. Oct 1976 A
4011602 Rybicki et al. Mar 1977 A
4051598 Sneer Oct 1977 A
4145764 Suzuki et al. Mar 1979 A
4146936 Aoyagi et al. Apr 1979 A
4180910 Straumann et al. Jan 1980 A
4195409 Child Apr 1980 A
4199864 Ashman Apr 1980 A
4223412 Aoyagi et al. Sep 1980 A
4261350 Branemark et al. Apr 1981 A
4330891 Branemark et al. May 1982 A
4336618 Raab Jun 1982 A
4366183 Ghommidh et al. Dec 1982 A
4406761 Shimogori et al. Sep 1983 A
4530116 Frey Jul 1985 A
4547157 Driskell Oct 1985 A
4547327 Bruins et al. Oct 1985 A
4608052 Van Kampen et al. Aug 1986 A
4629464 Takata et al. Dec 1986 A
4654314 Takagi et al. Mar 1987 A
4687675 Nakano et al. Aug 1987 A
4693986 Vit et al. Sep 1987 A
4702930 Heide et al. Oct 1987 A
4704126 Baswell et al. Nov 1987 A
4722688 Lonca Feb 1988 A
4746532 Suzuki et al. May 1988 A
4818559 Hama et al. Apr 1989 A
4826434 Krueger May 1989 A
4839215 Starling Jun 1989 A
4861733 White Aug 1989 A
4865603 Noiles Sep 1989 A
4871578 Adam et al. Oct 1989 A
4874434 Riggs, Jr. Oct 1989 A
4878914 Miwa et al. Nov 1989 A
4882196 Shimamune et al. Nov 1989 A
4908030 Linkow et al. Mar 1990 A
4911953 Hosonuma et al. Mar 1990 A
4919751 Sumita et al. Apr 1990 A
4932868 Linkow et al. Jun 1990 A
4938938 Ewers et al. Jul 1990 A
4944754 Linkow et al. Jul 1990 A
4960646 Shimamune et al. Oct 1990 A
4963145 Takagi et al. Oct 1990 A
4969906 Kronman Nov 1990 A
4988299 Branemark Jan 1991 A
5000685 Brajnovic Mar 1991 A
5030096 Hurson et al. Jul 1991 A
5032552 Nonami et al. Jul 1991 A
5034352 Vit et al. Jul 1991 A
5039546 Chung et al. Aug 1991 A
5071351 Green et al. Dec 1991 A
5108399 Eitenmuller et al. Apr 1992 A
5141576 Shimamune et al. Aug 1992 A
5180564 Wahl et al. Jan 1993 A
5188800 Green et al. Feb 1993 A
5190795 Culler Mar 1993 A
5195891 Sulc Mar 1993 A
5199873 Schulte et al. Apr 1993 A
5205745 Kamiya Apr 1993 A
5205921 Shirkanzadeh Apr 1993 A
5219361 von Recum et al. Jun 1993 A
5222983 Schmitz et al. Jun 1993 A
5242706 Cotell et al. Sep 1993 A
5258030 Wolfarth et al. Nov 1993 A
5263986 Noiles et al. Nov 1993 A
5279831 Constantz et al. Jan 1994 A
5297963 Dafatry Mar 1994 A
5306305 Lee Apr 1994 A
5310464 Redepenning May 1994 A
5316476 Krauser May 1994 A
5316477 Calderon May 1994 A
5324199 Branemark Jun 1994 A
5344425 Sawyer Sep 1994 A
5344457 Pilliar et al. Sep 1994 A
5360448 Thramann Nov 1994 A
5362237 Chalifoux Nov 1994 A
5366374 Vlassis Nov 1994 A
5368480 Balfour et al. Nov 1994 A
5368483 Sutter et al. Nov 1994 A
5399090 Padros-Fradera Mar 1995 A
5405436 Maurer et al. Apr 1995 A
5427754 Nagata et al. Jun 1995 A
5433606 Niznick et al. Jul 1995 A
5441536 Aoki et al. Aug 1995 A
5456723 Steinemann et al. Oct 1995 A
5472734 Perrotta et al. Dec 1995 A
5478237 Ishizasawa Dec 1995 A
5484286 Hansson Jan 1996 A
5489210 Hanosh Feb 1996 A
5496399 Ison et al. Mar 1996 A
5503558 Clokie Apr 1996 A
5543019 Lee et al. Aug 1996 A
5564923 Grassi et al. Oct 1996 A
5571017 Niznick Nov 1996 A
5571188 Ellingsen et al. Nov 1996 A
5573401 Davidson et al. Nov 1996 A
5588838 Hansson et al. Dec 1996 A
5591029 Zuest Jan 1997 A
5603338 Beaty Feb 1997 A
5607480 Beaty Mar 1997 A
5639237 Fontenot Jun 1997 A
5816811 Beaty Oct 1998 A
5863201 Lazzara et al. Jan 1999 A
5876453 Beaty Mar 1999 A
5989027 Wagner et al. Nov 1999 A
6069295 Leitao May 2000 A
6491723 Beaty Dec 2002 B1
6652765 Beaty Nov 2003 B1
7048870 Ellingsen et al. May 2006 B1
Foreign Referenced Citations (19)
Number Date Country
328 067 May 1975 AT
926552 May 1973 CA
2 313 678 Oct 1974 DE
27 17 615 Oct 1978 DE
202 031 Nov 1986 EP
212 929 Mar 1987 EP
0 213 836 Nov 1987 EP
0 409 810 Jan 1991 EP
455 929 Jan 1991 EP
606 566 Jul 1994 EP
2 289 160 Oct 1974 FR
2 421 595 Mar 1979 FR
834256 May 1960 GB
2045083 Jan 1984 GB
2252501 Aug 1992 GB
1148254 Jun 1989 JP
332 486 Nov 1971 SE
WO 9205745 Apr 1992 WO
WO 9413334 Jun 1994 WO
Related Publications (1)
Number Date Country
20010004711 A1 Jun 2001 US
Provisional Applications (1)
Number Date Country
60009592 Jan 1996 US
Continuations (1)
Number Date Country
Parent 08778503 Jan 1997 US
Child 09237605 US
Continuation in Parts (2)
Number Date Country
Parent 08607903 Feb 1996 US
Child 08778503 US
Parent 08351214 Nov 1994 US
Child 08607903 US